Novel nanofiber-based technology could help prevent HIV/AIDS transmission

Promising research to be featured at 2014 AAPS Annual Meeting and Exposition

2014-11-04

(Press-News.org) San Diego — Scientists have developed a novel topical microbicide loaded with hyaluronic acid (HA) nanofibers that could potentially prevent transmission of the human immunodeficiency virus (HIV) through the vaginal mucosa. This research is being presented at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Diego, Nov. 2-6. HIV is an infectious virus that attacks T lymphocytes, a type of white blood cell that prevents infections and disease. Over time, HIV dramatically depletes the body's T cell population, leaving the body defenseless against opportunistic pathogens. HIV is transmitted through direct contact with blood, semen, pre-seminal fluid, vaginal fluids, rectal fluids, or breast milk from an infected person. According to AIDS.gov, the Center for Disease Control and Prevention estimates that more than 1 million persons aged 13 years and older are living with HIV infection, including 180,900 who are unaware that they have the virus. To date, there is no functional cure for HIV infection/AIDS. Currently available anti-HIV drug delivery methods are formulated as gels and suppositories, but can lack appropriate vaginal retention, are prone to medicine leakage, and may cause uncomfortable wetness. To address these issues, Bi-Botti Youan, Ph.D and his colleagues from University of Missouri-Kansas City School of Pharmacy developed an anti-HIV drug loaded onto a mucoadhesive hyaluronic acid (HA) nanofiber delivery system. This delivery system is intended to stop HIV transmission through the vaginal mucosa, providing a triggered release upon exposure to semen fluid during sexual intercourse. The researchers used an electrospinning method to prepare the nanofibers loaded with tenofovir, a topical anti-HIV compound. Both semen enzyme-dependent nanofiber degradation and drug release were then measured using chemical and analytical assays. The cytotoxic effects of the nanofibers on human vaginal cells and on the Lactobacilli bacteria (L. crispatus) present in vaginal flora were also assessed. "The success of vaginal drug delivery systems depends on the length of time that the drug-containing formulation remains at the site of administration (ex. vagina, rectum). The mucoadhesive nanofibers developed in this study could be beneficial by causing much less discomfort and reducing the dosing frequency simultaneously due to their prolonged retention at the target site," said Youan. The nanofiber-based formulation offers various potential advantages in vaginal drug delivery, including the ability to adapt delivery systems for different medical needs, with no leakage or messiness after their application. Furthermore, this technology could be beneficial in protecting drug molecules against enzymatic and other degradation that can occur in the body. Since human semen is the carrier of HIV virus transmission during male to female intercourse, a semen enzyme-triggered nanofiber delivery system as used in this study has the potential to inactivate or kill the HIV virus prior to exposure and penetration of the vaginal mucosa. The next stage of Youan's research is to examine the safety and efficacy of the hyaluronic acid-based nanofiber templates. Further in vivo studies will be carried out using animal models to characterize the viral transmission, inhibition, potential biodistribution, pharmacokinetics, vaginal retention time, safety and immunological responses to the nanofibers.

INFORMATION:

This work was supported by grant number R01AI087304 from the National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA).

The 2014 AAPS Annual Meeting and Exposition aims to improve global health through advances in pharmaceutical sciences, and there will be over 470 exhibiting companies and an estimated 7,000 attendees. The meeting features nearly 245 programming sessions, including more than 65 symposia and roundtables and more than 2190 posters. Download the AAPS mobile application for additional information.

All press must provide press credentials to attend this meeting and register on-site in the press room 5AB. To schedule an interview with Dr. Youan or for any other press inquiry, please contact Amanda Johnson at ajohnson@spectrumscience.com or 202-587-2520 or Saara Khadir at skhadir@spectrumscience.com or 202-587-2519.

About AAPS The American Association of Pharmaceutical Scientists is a professional, scientific society of approximately 10,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to serve the public and enhance their contributions to health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. For more information, please visit http://www.aaps.org. Follow us on Twitter @AAPSComms; official Twitter hashtag for the meeting is: #AAPS2014.

ELSE PRESS RELEASES FROM THIS DATE:

Medicare may need to expand options for behavioral weight loss counseling in primary care

2014-11-04

PHILADELPHIA – An important addition to the "eat less, move more" strategy for weight loss lies in behavioral counseling to achieve these goals. But research on how primary care practitioners can best provide behavioral weight loss counseling to obese patients in their practices — as encouraged by the Centers for Medicare and Medicaid Services (CMS) — remains slim, according to a systematic review of this topic published today in JAMA. The study was led by researchers from the Perelman School of Medicine at the University of Pennsylvania. "After an ...

Autism spectrum disorder: 10 tips guidance article

2014-11-04

Washington D.C., November 4, 2014 – A Clinical Perspectives article published in the November 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry proposes a tool to empower stakeholders, guide caregivers, and provide a rationale for advocates, when considering the systems of support offered to people with an autism spectrum disorder (ASD). Organizations such as the American Academy of Child and Adolescent Psychiatry, the European Society for Child and Adolescent Psychiatry, the International Association for Child and Adolescent Psychiatry ...

NASA's SDO sees a mid-level solar flare: Nov. 3

2014-11-04

The sun emitted a mid-level solar flare, peaking at 5:40 p.m. EST on Nov. 3, 2014. NASA's Solar Dynamics Observatory, which watches the sun constantly, captured an image of the event. Solar flares are powerful bursts of radiation. Harmful radiation from a flare cannot pass through Earth's atmosphere to physically affect humans on the ground, however -- when intense enough -- they can disturb the atmosphere in the layer where GPS and communications signals travel. To see how this event may affect Earth, please visit NOAA's Space Weather Prediction Center at http://spaceweather.gov, ...

When less is more: Death in moderation boosts population density in nature

2014-11-04

In nature, the right amount of death at the right time might actually help boost a species' population density, according to new research that could help in understanding animal populations, pest control and managing fish and wildlife stocks. In a paper in the journal Trends in Ecology and Evolution, a Princeton University researcher and European colleagues conclude that the kind of positive population effect an overall species experiences from a loss of individuals, or mortality, depends on the size and developmental stage of the creatures that die. If many juveniles ...

Brain changes linked to prematurity may explain risk of neurodevelopmental disorders

2014-11-04

Disturbances in the early stages of brain growth, such as preterm birth – when many of the brain's structures have not yet fully developed – appears to affect the brain's neuro-circuitry, which may explain premature babies' higher risk of neurodevelopmental disorders including ADHD and autism spectrum disorder. Researchers led by Natasha Lepore, PhD, of The Saban Research Institute of Children's Hospital Los Angeles, have located significant alterations to specific surface regions of the brain. Described in a study published online this week by the journal ...

High-speed 'label-free' imaging could reveal dangerous plaques

2014-11-04

WEST LAFAYETTE, Ind. – Researchers are close to commercializing a new type of medical imaging technology that could diagnose cardiovascular disease by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. The system takes precise three-dimensional images of plaques lining arteries and identifies deposits that are likely to rupture and cause heart attacks, said Ji-Xin Cheng (pronounced Jee-Shin), a professor in Purdue University's Weldon School of Biomedical Engineering and Department of Chemistry. The imaging reveals the presence of carbon-hydrogen ...

Hot flushes are going unrecognized, leaving women vulnerable

2014-11-04

Hot flushes are one of the most distressing conditions faced by women who have been treated for breast cancer, but they are not being adequately addressed by healthcare professionals and some women consider giving up their post cancer medication to try and stop them, a new study has shown. More than 70 per cent of women who have had breast cancer experience menopausal problems, and hot flushes in particular, which are among the most prevalent and potentially distressing problems following breast cancer treatment. These can also be long lasting, persisting for more than ...

How cells defend themselves against antibiotics and cytostatic agents

2014-11-04

This news release is available in German. "On the one hand, ABC transporters causes diseases such as cystic fibrosis, while on the other hand they are responsible for the immune system recognising infected cells or cancer cells," explains Professor Robert Tampé from the Institute for Biochemistry at the Goethe University. The considerable medical, industrial and economic significance of ABC transporters is also based on the fact that they cause bacteria and other pathogens to become resistant to antibiotics. Likewise, they can help cancer cells to defend themselves ...

The inside story: How the brain and skull stay together

2014-11-04

CORAL GABLES, Fla. (November 4, 2014) — Think about the way our bodies are assembled during early development and ask: How do neighboring cells know that they are supposed to become a nerve or a bone cell and how do these tissues find the correct place and alignment? Researchers at the University of Miami (UM) are answering these crucial questions. In a new study, UM researchers describe the signaling systems that tissues use to communicate with their surrounding neighbors, at the head-trunk region. Their discovery may have important implications for the treatment ...

Preventing postpartum hemorrhage

2014-11-04

Sublingual misoprostol is inferior to intramuscular oxytocin for the prevention of postpartum hemorrhage (PPH) in women undergoing uncomplicated birth at a regional hospital in Uganda, according to trial results published in PLOS Medicine. The randomized non-inferiority trial, conducted by Esther Cathyln Atukunda at the Mbarara University of Science and Technology, Uganda, and colleagues, showed that PPH incidence in the misoprostol arm exceeded that in the oxytocin arm by 11.2% (95% confidence interval 6.44%-16.1%). PPH is responsible for 25–30% of maternal deaths. ...

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Novel nanofiber-based technology could help prevent HIV/AIDS transmission

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: